Literature DB >> 3595604

Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver.

A Yamamoto, O Wada, T Ono.   

Abstract

A low-molecular-mass chromium-binding substance (LMCr), which is recognized as a detoxification ligand of chromium, was isolated from the livers of rabbits injected intravenously with K2Cr2O7 (200 mumol Cr/kg body wt) as a biologically active form. LMCr appears as an anionic, organic Cr compound with a relative molecular mass of 1500. It is composed of glutamic acid or glutamine, glycine, cysteine and aspartic acid or asparagine with a Cr/amino-terminal residue ratio of 4:1. The purified LMCr (10-300 ng Cr/ml) shows in vitro activities comparable to those of glucose tolerance factor in relation to insulin action. In the presence of insulin it enhances [U-14C]glucose conversion to 14CO (23-30% up) in rat epididymal adipocytes above the value obtained with insulin alone. LMCr also stimulates the rate of [3-3H]glucose incorporation into lipid by 30-40% with insulin or by 15-23% without insulin, as compared with the basic value obtained with insulin alone or without insulin. These findings suggest that LMCr plays essential roles in both glucose metabolism and detoxification of invaded Cr in the body.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595604     DOI: 10.1111/j.1432-1033.1987.tb11486.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Isolation and characterization of low-molecular-weight chromium-binding substance (LMWCr) from chicken liver.

Authors:  Margarita Viera; C Michele Davis-McGibony
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

Review 2.  Molecular mechanisms of chromium in alleviating insulin resistance.

Authors:  Yinan Hua; Suzanne Clark; Jun Ren; Nair Sreejayan
Journal:  J Nutr Biochem       Date:  2012-04       Impact factor: 6.048

3.  Spectroscopic and biological activity studies of the chromium-binding peptide EEEEGDD.

Authors:  Hirohumi Arakawa; Machender R Kandadi; Evgeniy Panzhinskiy; Kenneth Belmore; Ge Deng; Ebony Love; Preshus M Robertson; Juliette J Commodore; Carolyn J Cassady; Sreejayan Nair; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2016-02-22       Impact factor: 3.358

4.  The time-dependent transport of chromium in adult rats from the bloodstream to the urine.

Authors:  Buffie J Clodfelder; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2005-04-27       Impact factor: 3.358

5.  Characterization of the organic component of low-molecular-weight chromium-binding substance and its binding of chromium.

Authors:  Yuan Chen; Heather M Watson; Junjie Gao; Sarmistha Halder Sinha; Carolyn J Cassady; John B Vincent
Journal:  J Nutr       Date:  2011-05-18       Impact factor: 4.798

6.  Kinetics and Mechanisms of the Chromium(III) Reactions with 2,4- and 2,5-Dihydroxybenzoic Acids in Weak Acidic Aqueous Solutions.

Authors:  Kimon Zavitsanos; Athinoula L Petrou
Journal:  Bioinorg Chem Appl       Date:  2010-07-11       Impact factor: 7.778

Review 7.  Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes.

Authors:  Francis C Lau; Manashi Bagchi; Chandan K Sen; Debasis Bagchi
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

8.  Featured Article: Inhibition of diabetic cataract by glucose tolerance factor extracted from yeast.

Authors:  Nitsa Mirsky; Revital Cohen; Anat Eliaz; Ahuva Dovrat
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28

9.  Trace elements in glucometabolic disorders: an update.

Authors:  Nicolas Wiernsperger; Jeanrobert Rapin
Journal:  Diabetol Metab Syndr       Date:  2010-12-19       Impact factor: 3.320

10.  Reaction of chromium(III) with 3,4-dihydroxybenzoic acid: kinetics and mechanism in weak acidic aqueous solutions.

Authors:  Kimon Zavitsanos; Konstantinos Tampouris; Athinoula L Petrou
Journal:  Bioinorg Chem Appl       Date:  2009-02-04       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.